BioCentury
ARTICLE | Clinical News

Winston's nasal spray meets migraine endpoint

November 23, 2010 2:00 AM UTC

Winston Pharmaceuticals Inc. (Pink:WPHM) said twice-daily Dolorac Nasal Solution met the co-primary endpoints of significantly reducing headache duration and significantly improving patient global sat...